Unixell Advances in Cell Therapy with CDE IND Acceptance
Shanghai-based Unixell Biotechnology Co., Ltd. has announced that its Investigational New Drug (IND) application for...
Insight, China's Pharmaceutical Industry
Fineline Insights, Pharma Clarity